Filing Flows › Angiodynamics (ANGO) › Capital expenditures
Angiodynamics (ANGO) capital expenditures by quarter
Angiodynamics' capital expenditures were $413K in Q4 FY26 (fourth quarter fiscal 2026), -2% from Q2 FY26. Over the last 3 quarters it ranged from $413K (Q4 FY26) to $777K (Q4 FY25).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q4 FY26 | $413K | -2% | -47% |
| Q2 FY26 | $422K | -46% | — |
| Q4 FY25 | $777K | — | — |
Q4 FY26 at a glance
Angiodynamics, Q4 FY26: revenue $86.6M (+8% year over year), operating margin -11.8%, net loss $11.4M, operating cash flow $17.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Angiodynamics' capital expenditures?
Angiodynamics' capital expenditures were $413K in Q4 FY26 (fourth quarter fiscal 2026), -2% from Q2 FY26.
How has Angiodynamics' capital expenditures changed?
Over the last 3 quarters it ranged from $413K (Q4 FY26) to $777K (Q4 FY25).